MyResults.Org

Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

Text Size:

Overview

What is Catecholaminergic Polymorphic Ventricular Tachycardia?
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a heart disorder, where the main features are abnormal heart rhythms, causing a person to faint. The abnormal rhythms are usually only apparent during or after exercise, or when a person is unusually stressed. For some people, the symptoms are confined to dizziness and fainting, but for others, abnormal heart rhythms can cause cardiac arrest (i.e. the heart suddenly stops beating) and lead to sudden death. For people with CPVT, the first symptom (usually fainting) appears when they are 7-12 years old, though some may not experience symptoms until 30 years of age or older.

Changes in four genes – RYR2, CASQ2, TRDN, and CALM1 – are known to cause CPVT, though the American College of Medical Genetics recommends systematic testing and returning results for only RYR2, which is by far the most common cause.

The main treatment for CPVT is to use beta-blocker drugs to control heart rhythms. People who do not respond well to drug treatments may need a small device placed near their heart, called an implantable cardioverter defibrillator (ICD). Other ways to help manage CPVT include educating patients about avoiding certain activities/sports, and making other lifestyle changes.

For most people that have a genetic change related to CPVT, there is a 50% chance each of their children will inherit this gene. A brother, sister, or parent of a person who has a CPVT risk gene also has a 50% chance of inheriting this risk.

Other names for CPVT are familial polymorphic ventricular tachycardia (CPVT) and catecholamine-induced polymorphic ventricular tachycardia.

Changes in several genes, including RYR2, CASQ2, TRDN, and CALM1 are known to cause CPVT. RYR2 is the most common cause, and 83% of people with a RYR2 risk gene will develop the disorder. Source: Napolitano et al, 2014, GeneReviews. Image created by Iconarray.com. Risk Science Center and Center for Bioethics and Social Sciences in Medicine, University of Michigan. Accessed 2016-09-08.

What is the genetic test?
Genetic testing allows us to identify people at risk of developing CPVT. Changes in several genes including RYR2, CASQ2, TRDN, and CALM1 are known to cause CPVT. Genetic testing allows us to identify people most at risk. The American College of Medical Genetics recommends testing and returning results for the RYR2 gene, which is the most common cause. The genetic test can indicate if a person carries a genetic change associated with CPVT, as well as several other conditions discussed on this website.

How will this affect my health care?
People found to carry a change in the RYR2 gene associated with CPVT, should typically take a type of drug called a beta blocker, which can help to control heart rhythms. This is usually recommended, even if the person has not had a fainting episode. It is very important to follow a treatment plan, as about 30% of people with CPVT who do not receive treatment will have at least one cardiac arrest - their heart suddenly stops beating, leading to a high risk of sudden death. About 80% of people who are untreated will experience fainting spells. For the same reasons, it is very important for people with changes in other genes associated with CPVT to follow a treatment plan, which may involve treatment with beta-blockers and other drugs/strategies.

If a CPVT-associated risk gene has been found, frequent follow-up visits to a cardiologist--an expert in the heart--are recommended. These should be scheduled every 6-12 months, allowing him/her to check your heart rhythm and the success of treatments.
People with CPVT should be told to avoid competitive sport and other rigorous activities. You should also be told to avoid certain types of shrubs - foxglove, also known as digitalis.
Finally, if a risk gene has been found, several other tests are recommended to help manage the disease most effectively:

  • Resting electrocardiogram (ECG): This tests the electrical activity of your heart when at rest (i.e. not during exercise), and is usually normal in people with CPVT
  • Holter monitoring: This tests for abnormal heart rhythms over 24- or 48-hours, while a person wears a device that records electrical activity
  • Exercise stress test: During strenuous activity (or under stress), people with CPVT have abnormal heart rhythms. An exercise test can check for abnormal rhythms, and will help confirm diagnosis, and can also be used to check if drug treatments are working
  • Echocardiogram: This is a type of test that uses ultrasound waves to create an image of the heart, and to evaluate it for structural problems
  • Medical genetics consultation: This can help educate people about the risks to themselves and to their families, and can also help educate us about changes in lifestyle and sports activities that are needed.

Who is at risk?
CPVT is rare, and affects about 1 in 10,000 people. However, if a person’s mother or father has a change in a gene that is linked to CPVT, he or she has a 50% of inheriting this risk (i.e. a 1 in 2 chance). Similarly, if a person’s brother or sister has a CPVT risk gene, they will have a 50% risk of inheriting this risk. A person is also at increased risk if other relatives have CPVT.

As discussed above, if a person has a change in the RYR2 gene that is linked to CPVT, they have about an 83% chance of getting the disorder. For other genes linked to CPVT, there is also a much higher disease-risk.

Does my ancestry affect my risk?
There is no strong evidence to link CPVT with individuals of any particular ancestry.

More Questions? The National Society of Genetic Counselors has developed a directory to help locate genetic counseling services near you.

Treatment

The main treatment for CPVT is to use beta-blocker drugs to control heart rhythms. People with more severe symptoms, may need a small device placed near their heart, called an implantable cardioverter defibrillator (ICD).

What are the treatments for CPVT?
The main treatment for CPVT is to use beta-blocker drugs to control heart rhythms. People with more severe symptoms, may need a small device placed near their heart, called an implantable cardioverter defibrillator (ICD). Other ways to help manage CPVT include educating patients about avoiding certain activities/sports, and making other lifestyle changes.

  • Beta-blockers: Beta-blockers are the first treatment for people with CPVT. Beta-blockers reduce heart rate and affect electrical activity in the heart by altering how calcium is released in heart muscles. They have been shown to be effective in about 60% of people with the condition, and prevent fainting and other symptoms.
  • To help decide how well beta-blockers are working, regular exercise tests are very useful. These can check for abnormal rhythms by recording electrical activity/heart rhythms while a person exercises in a safe environment (hospital/clinical)
  • Other drug treatments: For patients who do not respond to beta-blockers, a drug called flecainide has recently been shown to help treat abnormal heart beats and fainting episodes in CPVT.
  • ICDs: People who do not respond well to drug treatments may need a small device placed near their heart, called an implantable cardioverter defibrillator (ICD). This can help reduce the risk of cardiac arrest, and is usually used with drug treatments.
  • Left cardiac sympathetic denervation (LCSD): For a small number of people who do not respond to drug treatment or ICD, LCSD may be recommended. This is a surgery that cuts part of the nerves to the heart, and takes about 40-45 minutes to perform. LCSD can have several unwanted side-effects, which are discussed just below.
  • Lifestyle/exercise changes: Competitive sports and other types of demanding exercise or physical activity should be avoided. For some people with CPVT, it may be okay to some types of light exercise, but this very much depends on results of stress tests (see above) and other factors. It can also be helpful to use a heart rate monitoring device to monitor heart rates between medical visits.
  • Agents to avoid: People with CPVT should avoid foxglove (also known as digitalis) as it can trigger abnormal heart beats.

Can treatments cause any problems?
Beta-blockers can have several side effects, particularly if used with other medications. For people with asthma, beta-blockers can induce bronchospasms.

Placing the ICD in the body can be complicated, and the surgery to install the device can sometimes be life-threatening. Using an ICD can also be problematic. Two of the most common problems are 1) a low rate of appropriate shocks, which happens about 8% to 15% of the time, and 2) a high rate of inappropriate shocks, which happens about 20% to 30% of the time. Important steps to avoid experiencing problems with an ICD include avoiding competitive sports and limiting many other types of sporting activity.Anxiety is a common side-effect for people who had an ICD. In rare instances, ICDs can become infected.

Side effect of LCSD include drooping of the upper eyelid (palpebral ptosis), loss of lung capacity (due to raised left hemidiaphragm), and lack of sweating from the left arm and face.

More Questions? The National Society of Genetic Counselors has developed a directory to help locate genetic counseling services near you.

Genetic Test

Why do a genetic test?
The main reason people develop CPVT is that they inherit a faulty gene that causes it. Genetic testing tells us who is most at risk for developing CPVT. Testing for certain genes is particularly important if they are considered to be 'medically actionable' - meaning test results can be used to improve health care. Because people at risk for CPVT often do not have any symptoms before a serious incident, it is important to know who is at risk in order to offer the chance of early health management.

In the embedded video, Dr. Dan Roden of Vanderbilt University discusses how genetic testing has begun to influence treatment of patients.

What is the test?
There are several types of genetic tests for risk of developing CPVT. To do a genetic test, a medical professional will use your DNA to try to see if you have risk genes previously associated with CPVT.

Many of the people who use this website are patients in hospitals who are part of the eMERGE network. These hospitals are using DNA sequencing to test patients for a number of diseases, including CPVT, as recommended by the American College of Medical Genetics and eMERGE network members. Test results found to be medically ‘actionable’ (meaning they can be used to in patient health care) will be returned to patients.

I am concerned whether I should be tested or not, what should I do?
The decision to be tested might be one of the most important decisions you have to make. There are many things you may want to consider. For some people, genetic testing can have positive health benefits, while others may feel a lot of stress and worry. You can read more about these issues in the Concerns & Risks section. It may help to think about testing for a while before making a decision. You may also find it helpful to discuss issues with those close to you, or with your doctor/health professional.

What will the test result mean?
This test will tell your doctor whether you are at risk of developing CPVT. We also test for a number of other diseases, as recommended for testing by the American College of Medical Genetics and the eMERGE network. If you are found to be at risk, your doctor or genetic counselor should help you understand your health care options.

What happens if I am found to be at risk?
If you are found to be at risk for any of the diseases that we test for, a health professional at your local site will attempt to contact you as soon as possible. Once we contact you, your doctor or genetic counselor should help you understand your health care options. These may include include increased monitoring of your health, including:

  • Doing ECG and stress tests to examine your heart rhythms.
  • Taking a detailed family history of related problems
  • Family members may also be tested for risk.
  • Having regular heart checks
  • At a certain point, other treatments may be recommended (see the Treatment tab above)

What happens if I am NOT found to be at risk?
If you are found NOT to be at risk for any of the diseases that we test for, you will likely NOT be contacted. However, a small number of patients may receive a medical report with results, while other patients may be re-contacted about another research study

If you have not been rec-contacted, please DO NOT ASSUME that you have been tested. There are a number of reasons testing may not have happened yet. For example, studies can sometimes take a very long time to complete, and DNA samples are often not usable because of quality-control issues.

How is the test being performed?
Testing is performed on your DNA, usually from a blood sample. For many patients, your hospital or treatment center may already have some of your DNA stored in a biobank. You may be asked for an additional sample or be asked to give us permission to do testing on the existing samples.

Will it hurt?
For some patients, we may need an additional blood sample. Taking blood may cause some pain, bleeding or bruising at the spot where the needle enters your body. Rarely, taking blood may cause fainting or infection.

Is it safe?
There is a risk that you may experience pain or bleeding if you need to give an additional blood sample. Risks concerning privacy are discussed under Concerns & Risks.

How long will I have to wait for results?
Unfortunately, we cannot give an accurate estimate for the time you will have to wait for results - this will depend on the resources available at the location where you receive treatment and were tested.

Is this a standard test?
Although increasingly more common, this test is not yet standard, and is typically offered as part of a research study.

What type of test is this?

  • Is this test intended to help make a diagnosis? Yes
  • Is this test intended to predict a family history of disease? Yes
  • Is this test intended to check if I am a carrier for a particular disease? Yes
  • Is this test intended to screen for genetic disorders? Yes
  • Is this test intended to screen for disorders related to pregnancy? No
  • Is this test intended to screen for disorders related to newborns? No

Will I need to have this test done more than once?
No, you should not need to have this test done more than once. You will need to keep track of your testing result in order to share with all of your doctors, including those you see at other medical care centers.

More Questions? The National Society of Genetic Counselors has developed a directory to help locate genetic counseling services near you.

Family

Will my genetic test results affect my family?
Your genetic test results may affect your family. In the embedded video, Maureen Smith, a researcher at Northwestern University, recommends first discussing genetic test results with your doctor. Your doctor may refer you to a genetic counselor, who can help you understand test results and guide you toward brochures and websites that can provide information for both you and your family.

  • Before your genetic test: Because genetic information is inherited, it is important to be aware that your genetic test results are often relevant to your family members as well. Results may indicate that you are at risk, or that you are a carrier (see below). Before you have a genetic test, it can be a good idea to think about if and how you would like to share results with your family. Your doctor or genetic counselor should be able to provide more information about this.
  • After your genetic test: For many of the diseases we test for, genetic test results may be relevant to your family members, as well as to you. You may be at risk, and you may be a carrier (see below). If you already have results, it is again important to think about sharing them with family. Again, your doctor or genetic counselor should be able to offer advice on how genetic testing may affect your family members.

Can you (briefly) explain heritability?
We each have about 24,000 genes, which carry the instructions for making and maintaining our bodies. For each gene we typically have two copies – one inherited from each parent. If genetic test results suggest you are at risk of developing a heritable disease, you will have inherited the risk from one or both your parents. Your brothers, sisters, children, parents, and other relatives may also be at risk of developing the same disease.
There are several ways we can inherit a genetic disease, which relates to whether it is recessive or dominant.

  • For a dominant condition, only one copy of a gene needs to be faulty to cause a disease. In this case, if you have one copy of a faulty gene, you may be at high risk of developing the disease. You could pass this faulty gene to one your child or children. Most types of CPVT are dominant conditions.
  • For a recessive condition BOTH copies of a gene must be faulty to cause a disease. In this case, if a person has only one copy of a faulty gene, they may not be at much greater risk. However, they may pass the faulty gene to their children. Again, this person is called a carrier. CPVTis NOT a recessive condition.
Please note that the Resources section provides links to a number of websites that provide a much more detailed explanation of inheritance! Learn.Genetics at the University of Utah have a much more detailed explanation, which we find quite good – you can check it out here.

What family members could be affected?
If you have CPVT related to genetic changes, there is a 50% your child will have these genetic changes. For each of your brothers or sisters, there is also a 50% chance of having these genetic changes. Other family members are also at a much higher risk of having CPVT.

My children are under 18 years of age – should they be tested?
The American College of Medical Genetics recommend testing children for most of the diseases listed on this website. Health management can be effective in children at risk of CPVT before they reach 18 years of age.

More Questions? The National Society of Genetic Counselors has developed a directory to help locate genetic counseling services near you.

Concerns & Risks

What Should I Do If I Have Concerns About Genetic Test Results?
If you are concerned about genetic test results you have received, you should discuss your concerns with your doctor. Your doctor should be able to explain results to you, and may recommend you to a genetic counselor or another doctor that can further help you understand your results. Maureen Smith, a researcher at Northwestern University, discusses these concerns in the embedded video.

Is there a reason why I may be a specific risk?
For most of the disorders discussed on this site, the American College of Medical Genetics recommends genetic testing for individuals with available genetic data.

Are there any implications for having children?
Yes, please see the Family section

Can I expect to experience emotional consequences related to my test result?
A range of reactions are possible and normal. Some patients may experience anxiety or other negative reactions related to genetic testing and results. If this is the case, please discuss with your doctor, who can address your concerns and refer you another health professional if required.

Can I expect to experience social consequences related to my test result?
Some people may feel that there is a stigma attached to having a genetic disease. If you do experience or anticipate any negative social reactions, please discuss with your doctor who can address your concerns.

Can I expect to experience an increase in anxiety?
Many individual experience increased anxiety related to genetic testing. Again, please discuss with your doctor if this is the case.

Are there any implications in terms of discrimination arising from the test result?
Health insurance companies are prevented by law from discriminating against you based on your genetic test results. However, the same law does not apply to long-term disability insurance or to life insurance. Maureen Smith, a researcher at Northwestern University discussed these issues in the video on this page.

If I am found to be at increased risk for developing a disease, are there similar health implications for my family?
Yes, your results may have similar health implications for your family. Please see the Family section.

More Questions? The National Society of Genetic Counselors has developed a directory to help locate genetic counseling services near you.

Sharing

Should I tell other health care providers about my test result?
We do recommend that you share this information with your health care providers. However, as explained by Maureen Smith, a researcher at Northwestern University, what you decide to do with your results is up to you.

Who will see my test results?
People who have access to your medical record will be able to see your genetic test result. This may include health professionals such as doctors, nurses, pharmacists, and genetic counselors. However, health professionals from other centers or hospitals will likely not have access to your results.

Should my other family members be tested?
If you are found to be at risk for a heritable genetic disease, your family may also be at risk. We discuss this further in the Family section.

Will this affect my health insurance?
No, your health insurance will not be affected by this test result. However, as discussed below by Maureen Smith, a researcher at Northwestern University, your life insurance and other areas of your life may be affected.

Who can I contact if they have any more questions?
You can contact your local center, where you received the test. The Resources section also includes a lot of websites that we recommend.

Is it there a risk to my privacy?
Research that uses information from medical records and that involves genetic testing can affect your privacy. Your participation in this research will be held strictly confidential, and only coded numbers will be used to identify specimens and research records. While it is impossible to absolutely guarantee that information in our secure system will never be known by others, we are taking every possible precaution to see that this does not happen.

More Questions? The National Society of Genetic Counselors has developed a directory to help locate genetic counseling services near you.

Resources

We are compiling a list of websites to help you understand genetics and genetic test results. If you would like to suggest other resources for this section, please feel free to This email address is being protected from spambots. You need JavaScript enabled to view it.!
INFORMATION ABOUT CPVT:

Weblink to Genetics Home ReferenceGenetics Home Reference
Extensive resource about rare and genetic and genetic diseases. The above link leads to their CPVT pages. A link to the main site is provided below as well.


Weblink to Genetic and Rare Diseases Center (GARD) - CPVT ResourcesGenetic and Rare Diseases Center (GARD)
Supported by the NIH, this website has great resources for a huge range of genetic and rare diseases. The above link is to their CPVT resource. A link to the main GARD site is provided below as well.


INFORMATION ABOUT GENETICS AND GENETIC TESTING:

Weblink to Genetics Home Reference Genetics Home Reference
Consumer-friendly information about the effects of genetic variations on human health. Federally-supported resources, include reviews of more than 800 genetic diseases and more than 1000 genes.


Weblink to Learning Resources from the NHGRILearning Resources from the NHGRI
Lots of very good resources from the NHGRI, including major sections about The Human Genome Project, Facts Sheets, and educational resources for teachers and students.


Weblink to National Society of Genetic CounselorsFind a Genetic Counselor
The National Society of Genetic Counselors have a searchable database of genetic counselors. Their website also includes some education materials for patients and healthcare professionals.


Weblink to NHGRI Talking GlossaryNHGRI Talking Glossary
Talking glossary of genetic terms developed by the National Human Genome Research Institute. A huge range of definitions is provided by researchers from around the world.


Weblink to Help Me Understand GeneticsHelp Me Understand Genetics
Help Me Understand Genetics is a handbook from the National Institutes of Health that contain useful information about genetics in clear language and provides links to even more online resources. The entire handbook can also be downloaded as a pdf.


Weblink to the Genetic and Rare Diseases Information CenterGenetic and Rare Diseases Information Center (GARD)
A joint project from The Office of Rare Diseases Research (ORDR) and the National Human Genome Research Institute (NHGRI) that provides searchable information about genetic conditions and rare diseases. It also includes a list of FDA-Approved drugs and other medical products for treating rare disease.


Weblink to NORDNational Organization for Rare Disorders - Resources for Parents/Families
The National Organization for Rare Disorders (NORD) is a volunteer organization dedicated to empowering the rare disease community. Again, they have some very nice web resources.


Weblink to ELSIEthical, Legal and Social Implications Research Program
The ELSI Research Program supports examinations and investigations of the ethical, legal and social implications of genetics research.


Weblink to GINAGenetic Information Nondiscrimination Act of 2008
The Genetic Information Nondiscrimination Act of 2008, also referred to as GINA, is a new federal law that protects Americans from being treated unfairly because of differences in their DNA that may affect their health.


Weblink to Learn.GeneticsLearn.Genetics, University of Utah
Excellent resources, especially for those involved in education. Includes a catalog of animations, videos, interactive features, and virtual labs.


Weblink to the Dolan DNA Learning CenterDolan DNA Leaning Center
The DNALC provides genetics learning resources for teachers and students.


INFORMATION FOR RESEARCHERS:

Weblink to the ClinVar ACMG recommendations pageClinVar: ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing
Clinvar's dedicated ACMG page - a useful jumping-off point to the Genetic Testing Registry, OMIM, MedGen, and local ClinVar pages for each gene.


Weblink to CPVT GeneReviews pageGeneReviews
McNally et al. GeneReviews: Catecholaminergic Polymorphic Ventricular Tachycardia (updated March, 2014).


About

What is the purpose of this information?
Our aim is to provide information about why we do genetic testing. We try to answer some common questions and offer guidance on some personal and practical issues. This information is for anybody with questions about genetic testing for any of the diseases and drugs listed in this site.

Are there geographical differences in testing, service or treatment?
Different centers have different policies in terms of how tests are administered and results shared. However, the results discussed in this document should be relevant to most individuals tested for risk of developing genetic disease.

How is this paid for?
If you received this test as part of the eMERGE research study, neither you nor your insurance company will have to pay anything toward this test

When was this content last updated?
September 9, 2016.

More Questions? The National Society of Genetic Counselors has developed a directory to help locate genetic counseling services near you.
You are here: Home Results Explore by Disorder Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)